These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32297044)

  • 1. Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods.
    Gomeni R; Bressolle-Gomeni F
    AAPS J; 2020 Apr; 22(3):67. PubMed ID: 32297044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.
    Kesisoglou F; Xia B; Agrawal NG
    AAPS J; 2015 Nov; 17(6):1492-500. PubMed ID: 26290380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convolution-based approaches for in vivo-in vitro correlation modeling.
    Gillespie WR
    Adv Exp Med Biol; 1997; 423():53-65. PubMed ID: 9269483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deconvolution Analysis by Non-linear Regression Using a Convolution-Based Model: Comparison of Nonparametric and Parametric Approaches.
    Gomeni R; Bressolle-Gomeni F
    AAPS J; 2019 Dec; 22(1):9. PubMed ID: 31820258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A time scaling approach to develop an in vitro-in vivo correlation (IVIVC) model using a convolution-based technique.
    Costello C; Rossenu S; Vermeulen A; Cleton A; Dunne A
    J Pharmacokinet Pharmacodyn; 2011 Oct; 38(5):519-39. PubMed ID: 21735135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo correlation (IVIVC) models for metformin after administration of modified-release (MR) oral dosage forms to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Sci; 2001 Aug; 90(8):1176-85. PubMed ID: 11536222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Convolution- and Deconvolution-Based Approaches for Prediction of Pharmacokinetic Parameters of Diltiazem Extended-Release Products in Flow-Through Cell Dissolution Tester.
    Taha NF; Emara LH
    AAPS PharmSciTech; 2022 Jul; 23(6):202. PubMed ID: 35882726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of an NLME-Stochastic Deconvolution Approach to Level A IVIVC Modeling.
    Kakhi M; Suarez-Sharp S; Shepard T; Chittenden J
    J Pharm Sci; 2017 Jul; 106(7):1905-1916. PubMed ID: 28341596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time Scaling for In Vitro-In Vivo Correlation: the Inverse Release Function (IRF) Approach.
    Cardot JM; Lukas JC; Muniz P
    AAPS J; 2018 Aug; 20(6):95. PubMed ID: 30159772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An automated process for building reliable and optimal in vitro/in vivo correlation models based on Monte Carlo simulations.
    Sutton SC; Hu M
    AAPS J; 2006 May; 8(2):E307-13. PubMed ID: 16796381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal Delivery of Etoposide Phosphate II: In Vitro In Vivo Correlations (IVIVC).
    Patel H; Joshi A; Joshi A; Stagni G
    J Pharm Sci; 2016 Jul; 105(7):2139-45. PubMed ID: 27233686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo-in vitro correlation (IVIVC) modeling incorporating a convolution step.
    O'Hara T; Hayes S; Davis J; Devane J; Smart T; Dunne A
    J Pharmacokinet Pharmacodyn; 2001 Jun; 28(3):277-98. PubMed ID: 11468941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the prediction accuracy of two IVIVC modelling techniques.
    Gaynor C; Dunne A; Davis J
    J Pharm Sci; 2008 Aug; 97(8):3422-32. PubMed ID: 17990312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a Level A in vitro-in vivo correlation (IVIVC).
    Dutta S; Qiu Y; Samara E; Cao G; Granneman GR
    J Pharm Sci; 2005 Sep; 94(9):1949-56. PubMed ID: 16052544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro in-vivo correlation models for glibenclamide after administration of metformin/glibenclamide tablets to healthy human volunteers.
    Balan G; Timmins P; Greene DS; Marathe PH
    J Pharm Pharmacol; 2000 Jul; 52(7):831-8. PubMed ID: 10933133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of stereoselective pharmacokinetics in the development and predictability of an IVIVC for the enantiomers of metoprolol tartrate.
    Sirisuth N; Eddington ND
    Pharm Res; 2000 Aug; 17(8):1019-25. PubMed ID: 11028951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approach.
    Sánchez-Dengra B; González-García I; González-Álvarez M; González-Álvarez I; Bermejo M
    Eur J Pharm Biopharm; 2021 Jan; 158():185-197. PubMed ID: 33248267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deconvolution and IVIVC: Exploring the Role of Rate-Limiting Conditions.
    Margolskee A; Darwich AS; Galetin A; Rostami-Hodjegan A; Aarons L
    AAPS J; 2016 Mar; 18(2):321-32. PubMed ID: 26667356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct, differential-equation-based in-vitro-in-vivo correlation (IVIVC) method.
    Buchwald P
    J Pharm Pharmacol; 2003 Apr; 55(4):495-504. PubMed ID: 12803771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.